Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
PcrV
Description:
PcrV is a tip protein of the type III secretion system used by Pseudomonas aeruginosa to deliver virulence factors into host cells.
Primary topic:
Bacterial biofilms and quorum sensing (24%)
Related topics:
Bacterial biofilms and quorum sensing (24%),
Bacterial Infections and Vaccines (10%),
Monoclonal and Polyclonal Antibodies Research (8%)
OpenAlex ID:
keywords/pcrv
Type III Protein Secretion Is Associated with Death in Lower Respiratory and Systemic Pseudomonas aeruginosa Infections
2001
·
Arup Roy‐Burman
, Richard H. Savel
, et al.
·
The Journal of Infectious Diseases
·
522
Active and passive immunization with the Pseudomonas V antigen protects against type III intoxication and lung injury
1999
·
Teiji Sawa
, Timothy L. Yahr
, et al.
·
Nature Medicine
·
400
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
2014
·
Antonio DiGiandomenico
, Ashley E. Keller
, et al.
·
Science Translational Medicine
·
319
Pore‐forming activity of type III system‐secreted proteins leads to oncosis of Pseudomonas aeruginosa ‐infected macrophages
2001
·
Denis Dacheux
, Julien Goure
, et al.
·
Molecular Microbiology
·
218
PDF
The V Antigen of Pseudomonas aeruginosa Is Required for Assembly of the Functional PopB/PopD Translocation Pore in Host Cell Membranes
2004
·
Julien Goure
, Alexandrine Pastor
, et al.
·
Infection and Immunity
·
213
Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: A randomized,double-blind, placebo-controlled trial*
2012
·
Bruno François
, Charles-Edouard Luyt
, et al.
·
Critical Care Medicine
·
196
Generation and Characterization of a Protective Monoclonal Antibody to Pseudomonas aeruginosa PcrV
2002
·
Dara W. Frank
, Amy Vallis
, et al.
·
The Journal of Infectious Diseases
·
195
Function and molecular architecture of the Yersinia injectisome tip complex
2007
·
Petr Broz
, Catherine A. Mueller
, et al.
·
Molecular Microbiology
·
182
PDF
Yersinia enterocolitica Evasion of the Host Innate Immune Response by V Antigen-Induced IL-10 Production of Macrophages Is Abrogated in IL-10-Deficient Mice
2002
·
Andreas Sing
, Andreas Roggenkamp
, et al.
·
The Journal of Immunology
·
171
PDF
LcrV is a channel size‐determining component of the Yop effector translocon of Yersinia
2001
·
Anna Holmström
, Jan Olsson
, et al.
·
Molecular Microbiology
·
163
PDF
Protective Anti‐V Antibodies Inhibit Pseudomonas and Yersinia Translocon Assembly within Host Membranes
2005
·
Julien Goure
, Petr Broz
, et al.
·
The Journal of Infectious Diseases
·
157
Phase 1 study of MEDI3902, an investigational anti–Pseudomonas aeruginosa PcrV and Psl bispecific human monoclonal antibody, in healthy adults
2018
·
S.O. Ali
, X.Q. Yu
, et al.
·
Clinical Microbiology and Infection
·
146
PDF
A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models
2014
·
Paul Warrener
, Reena Varkey
, et al.
·
Antimicrobial Agents and Chemotherapy
·
137
An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
2008
·
Mark Baer
, Teiji Sawa
, et al.
·
Infection and Immunity
·
137
Therapeutic Administration of Anti-PcrV F(ab′)2 in Sepsis Associated with Pseudomonas aeruginosa
2001
·
Nobuaki Shime
, Teiji Sawa
, et al.
·
The Journal of Immunology
·
136
Strong immune responses and protection of PcrV and OprF-I mRNA vaccine candidates against Pseudomonas aeruginosa
2023
·
Xingyun Wang
, Cong Liu
, et al.
·
npj Vaccines
·
103
PDF
ExoS Controls the Cell Contact-Mediated Switch to Effector Secretion in Pseudomonas aeruginosa
2007
·
Michelle Cisz
, Pei-Chung Lee
, et al.
·
Journal of Bacteriology
·
102
PDF
Control of effector export by the Pseudomonas aeruginosa type III secretion proteins PcrG and PcrV
2010
·
Pei‐Chung Lee
, Charles M. Stopford
, et al.
·
Molecular Microbiology
·
99
PDF
Anti-PcrV antibody strategies against virulentPseudomonas aeruginosa
2014
·
Teiji Sawa
, Emi Ito
, et al.
·
Human Vaccines & Immunotherapeutics
·
98
PDF
PcrV Immunization Enhances Survival of Burned Pseudomonas aeruginosa -Infected Mice
2001
·
Ian Alan Holder
, Alice N. Neely
, et al.
·
Infection and Immunity
·
97
Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature
2017
·
Ajitha Thanabalasuriar
, Bas G.J. Surewaard
, et al.
·
Journal of Clinical Investigation
·
93
PDF
Effects of monoclonal anti-PcrV antibody on Pseudomonas aeruginosa-induced acute lung injury in a rat model
2003
·
Karine Faure
, Junichi Fujimoto
, et al.
·
Journal of Immune Based Therapies and Vaccines
·
90
PDF
Multi-Functional Characteristics of the Pseudomonas aeruginosa Type III Needle-Tip Protein, PcrV; Comparison to Orthologs in other Gram-negative Bacteria
2011
·
Hiromi Sato
, Dara W. Frank
·
Frontiers in Microbiology
·
89
PDF
Type IV pili are not specifically required for contact dependent translocation of exoenzymes by Pseudomonas aeruginosa
2002
·
Charlotta Sundin
, Matthew C. Wolfgang
, et al.
·
Microbial Pathogenesis
·
88
The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury
2014
·
Trevor C. Stevens
, Cristhiaan D. Ochoa
, et al.
·
American Journal of Physiology-Lung Cellular and Molecular Physiology
·
87
Show more works
View as search
Works count:
244
Citation count:
6,762
Year
Topic
Type